Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Hematology Analyzers and Reagents Market to Reach USD 12.10 Billion By 2027 | Reports And Data

This image opens in the lightbox

News provided by

Reports And Data

01 Sep, 2020, 13:30 GMT

Share this article

Share toX

Share this article

Share toX

The increasing number of blood donations and the growing amount of people suffering from blood disorders are driving the demand for the market.

Market Size – USD 7.00 Billion in 2019, Market Growth - CAGR of 7.1%, Market Trends – Increasing number of blood disorders.

NEW YORK, Sept. 1, 2020 /PRNewswire/ -- The Global Hematology Analyzers and Reagents Market is forecast to reach USD 12.10 Billion by 2027, according to a new report by Reports and Data. The growing demand from emerging markets will help the Hematology Analyzers and Reagents Market maintain a stable growth rate over the forecast period. The rise in disposable incomes and the growing adoption of automated hematology devices by clinical labs will provide strength to the Hematology Analyzers and Reagents Market and will also help in its growth over the forecast period.

Due to the pandemic, there are high chances of disruption in the supply chain, which influences ingredients and raw material supplies. The financial crisis can let people shrink their expenses on treatments, which may lead to life risk. Apart from barriers, there are some drivers of the Hematology Analyzers and Reagents Market, such as increasing blood donations, growing number of people affected by blood-related disorders, increasing investments in the research and development of hematology devices and usage of microfluidics technology in hematology instruments. The emerging economies of the world also provide a vast field of opportunities for the new players in the Hematology Analyzers and Reagents Market.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3483

COVID-19 Impact Analysis:

After the outbreak of the coronavirus, WHO encouraged people to take more aggressive steps to prevent the virus from spreading and to abide by the rules and regulations created by the respective governments of each country. Experts predicted that COVID-19 would have a negative effect on patients with blood-related disorders. Due to the lack of resources, more emphasis is laid on patients suffering from COVID-19 compared to patients suffering from other diseases. Thus, patients suffering from blood-related disorders might face negative consequences if they do not receive proper treatment. A delay in treating a blood cancer patient might lead to loss of life in severe cases. To avoid the transmission of COVID-19, doctors are practicing telemedicine with the patients suffering from a blood disorder, though the implementation is challenging. Currently, COVID-19 has created a barrier for both patients suffering from blood-related diseases and Hematology Analyzers and Reagents Market.

To identify the key trends in the industry, click on the link below:
https://www.reportsanddata.com/report-detail/hematology-analyzers-and-reagents-market

Further key findings from the report suggest

  • The increasing number of blood donations arranged by different organizations worldwide are boosting the Hematology Analyzers and Reagents Market. Additionally, the growing investment in the research and development of the hematology instrument made by the leading manufacturers are also acting as a driver for the Hematology Analyzers and Reagents Market.
  • The hematology products held the largest share of about 40.4% of the Hematology Analyzers and Reagents Market in 2019. The increasing production of technologically advanced devices and the growing adoption of Point of Care (POC) testing has generated revenue for the market.
  • Asia Pacific has the highest adoption rate in the market due to the increasing demand for Hematology Analyzers and Reagents in countries like China and India and recent developments in the healthcare infrastructure.
  • Hematology Analyzers and Reagents Market are adopting some wiser strategies to stay competitive in between the growing demand of the Hematology Analyzers and Reagents. Collaborations have been observed between prominent brands to increase their product portfolio and enter new markets. Companies adopt effective marketing and branding strategies to hold their position in the market.
  • Key participants include Abbott Laboratories, Roche Diagnostics, Siemens AG, Beckman Coulter, HORIBA Ltd, Nihon Kohden Corporation, Bio-Rad Laboratories, Sysmex Corporation, Boule Diagnostics AB, and Mindray Medical International Limited, among others.

Order Now: https://www.reportsanddata.com/checkout-form/3483

For the purpose of this report, Reports and Data has segmented the Global Hematology Analyzers and Reagents Market on the basis of product, price range, end-users, application, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

  • Hematology Analyzers
  • Hemostasis Analyzers
  • Plasma Protein Analyzers
  • Hemoglobin Analyzers
  • Immunohematology Analyzers
  • Others

Price range Outlook (Revenue, USD Billion; 2017-2027)

  • High-end Hematology Analyzers
  • Mid-range Hematology Analyzers
  • Low-end Hematology Analyzers

End Users Outlook (Revenue, USD Billion; 2017-2027)

  • Research & Academic Institutes
  • Blood Banks
  • Hospital laboratories
  • Commercial service Providers
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Infection Related Conditions
  • Blood Cancers
  • Anemia
  • Hemorrhagic
  • Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of MEA

Have a Look at Similar Research Reports:

Pen Needles Market - Pen needles offer several advantages over conventional needle and syringe device. These devices aid in self-administration of the medication and do not require any expertise.

Knee Replacement Implants Market - The artificial material used in knee replacement is referred to as an implant. It aids in the restoration of normal functions of the knee. The surgical procedures are very complex for people with severe deformities.

Bioactive Wound Care Market - Bioactive wound care comprises wound dressings that have biodegradable properties and are capable of combating microbial infections.

Bone Densitometer Market  - The method uses a very small dose of ionizing radiation to produce images of the internal body wherein low bone density could be observed.

Immunoassay Analyzers Market  - Immunoassay is a test to measure the concentration or presence of a molecule via an antibody or an antigen. The molecule detected through this test is termed as an 'analyte' and, in some cases, also as protein.

Bioprosthetics Market - The increasing prevalence of rheumatoid heart disease, coronary and peripheral artery diseases, and other cardiovascular diseases have led to the increasing demand for long-term treatment and relief, factors that are anticipated to drive bioprosthetics market growth.


About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read full Press Release at : https://www.reportsanddata.com/press-release/global-hematology-analyzers-and-reagents-market

Logo: https://mma.prnewswire.com/media/1009077/Reports_And_Data_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.